# OnCo record nct03288987 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct03288987/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct03288987", "NCT03288987" ;
  schema:name "Stivant (AryoGen bevacizumab) against Avastin in metastatic colorectal cancer"@en ;
  schema:alternateName "BE1040V phase 3"@en, "BEV.ARY.HR.94 (III)"@en ;
  schema:description "An Iranian phase 3 trial that found a locally made copy of bevacizumab worked as well as the original in bowel cancer that had spread."@en ;
  schema:url <https://onco.cc/trials/nct03288987/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03288987>, <https://doi.org/10.1016/j.clinthera.2020.03.009>, <https://pubmed.ncbi.nlm.nih.gov/32334845/> ;
  onco:status "completed" ;
  onco:phase "3" ;
  schema:startDate "2016-10-04" ;
  onco:cancers <https://onco.cc/cancers/colorectal/> ;
  onco:technologies <https://onco.cc/technologies/biosimilar-manufacturing/> ;
  onco:drugs <https://onco.cc/drugs/bevacizumab/> ;
  onco:companies <https://onco.cc/companies/aryogen-pharmed/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-be1040v-bevacizumab-biosimilar-clin-ther-2020/> .